Evaluating tissue plasminogen activator (tPA) in dialysis catheter dysfunction: A focus on fibrin sheath and risk factors
tPA therapy effectively restores catheter function in cases of fibrin sheath-related dysfunction. Addressing modifiable risk factors such as smoking and managing diabetes may help reduce the incidence of catheter dysfunction and improve long-term outcomes in dialysis patients.
Authors
- Touraj Asvadi
- Sarah Vaseghi (ORCID: https://orcid.org/0000-0002-5670-9102)
- Javad Jalili (ORCID: https://orcid.org/0000-0003-0588-2287)
- Mahdiyeh Baastani Khajeh
Institutions
- Tabriz University of Medical Sciences (IR)
Publication Details
- Journal
- American Heart Journal Plus Cardiology Research and Practice
- Published
- 2025-08-18
- DOI
- https://doi.org/10.1016/j.ahjo.2025.100595
- Citations
- 1
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 2.52